Literature DB >> 15564437

Mammalian septin function in hemostasis and beyond.

Constantino Martinez1, Jerry Ware.   

Abstract

Interest in the biology of mammalian septin proteins has undergone a birth in recent years. Originally identified as critical for yeast budding throughout the 1970s, the septin family is now recognized to extend from yeast to humans and is associated with a variety of events ranging from cytokinesis to vesicle trafficking. An emerging theme for septins is their presence at sites where active membrane or cytoplasmic partitioning is occurring. Here, we briefly review the mammalian septin protein family and focus on a prototypic human and mouse septin, termed SEPT5, that is expressed in the brain, heart, and megakaryocytes. Work from neurobiology laboratories has linked SEPT5 to the exocytic complex of neurons, with implications that SEPT5 regulates neurotransmitter release. Striking similarities exist between neurotransmitter release and the platelet-release reaction, which is a critical step in platelet response to vascular injury. Work from our laboratory has characterized the platelet phenotype from mice containing a targeted deletion of SEPT5. Most strikingly, platelets from SEPT5(null) animals aggregate and release granular contents in response to subthreshold levels of agonists. Thus, the characterization of a SEPT5-deficient mouse has linked SEPT5 to the platelet exocytic process and, as such, illustrates it as an important protein for regulating platelet function. Recent data suggest that platelets contain a wide repertoire of different septin proteins and assemble to form macromolecular septin complexes. The mouse platelet provides an experimental framework to define septin function in hemostasis, with implications for neurobiology and beyond.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15564437     DOI: 10.1177/153537020422901105

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  7 in total

1.  Superfluous role of mammalian septins 3 and 5 in neuronal development and synaptic transmission.

Authors:  Christopher W Tsang; Michael Fedchyshyn; John Harrison; Hong Xie; Jing Xue; Phillip J Robinson; Lu-Yang Wang; William S Trimble
Journal:  Mol Cell Biol       Date:  2008-09-22       Impact factor: 4.272

2.  Cloning, overexpression, purification and preliminary characterization of human septin 8.

Authors:  T A C B Souza; J A R G Barbosa
Journal:  Protein J       Date:  2010-07       Impact factor: 2.371

3.  The extracellular signal-regulated kinase 3 (mitogen-activated protein kinase 6 [MAPK6])-MAPK-activated protein kinase 5 signaling complex regulates septin function and dendrite morphology.

Authors:  Frank Brand; Stefanie Schumacher; Shashi Kant; Manoj B Menon; Ruth Simon; Benjamin Turgeon; Stefan Britsch; Sylvain Meloche; Matthias Gaestel; Alexey Kotlyarov
Journal:  Mol Cell Biol       Date:  2012-04-16       Impact factor: 4.272

Review 4.  Septin function in yeast model systems and pathogenic fungi.

Authors:  Lois M Douglas; Francisco J Alvarez; Cheryl McCreary; James B Konopka
Journal:  Eukaryot Cell       Date:  2005-09

5.  Screening of an endothelial cDNA library identifies the C-terminal region of Nedd5 as a novel autoantigen in systemic lupus erythematosus with psychiatric manifestations.

Authors:  Paola Margutti; Maurizio Sorice; Fabrizio Conti; Federica Delunardo; Mauro Racaniello; Cristiano Alessandri; Alessandra Siracusano; Rachele Riganò; Elisabetta Profumo; Guido Valesini; Elena Ortona
Journal:  Arthritis Res Ther       Date:  2005-05-20       Impact factor: 5.156

Review 6.  In the line-up: deleted genes associated with DiGeorge/22q11.2 deletion syndrome: are they all suspects?

Authors:  Zahra Motahari; Sally Ann Moody; Thomas Michael Maynard; Anthony-Samuel LaMantia
Journal:  J Neurodev Disord       Date:  2019-06-07       Impact factor: 4.025

7.  Analysis of septins across kingdoms reveals orthology and new motifs.

Authors:  Fangfang Pan; Russell L Malmberg; Michelle Momany
Journal:  BMC Evol Biol       Date:  2007-07-01       Impact factor: 3.260

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.